» Articles » PMID: 26324732

National Surveillance of Spotted Fever Group Rickettsioses in the United States, 2008-2012

Overview
Specialty Tropical Medicine
Date 2015 Sep 2
PMID 26324732
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Spotted fever group (SFG) rickettsioses are notifiable conditions in the United States caused by the highly pathogenic Rickettsia rickettsii and less pathogenic rickettsial species such as Rickettsia parkeri and Rickettsia sp. 364D. Surveillance data from 2008 to 2012 for SFG rickettsioses are summarized. Incidence increased from 1.7 cases per million person-years (PY) in 2000 to 14.3 cases per million PY in 2012. During 2008-2012, cases of SFG rickettsiosis were more frequently reported among males, persons of white race, and non-Hispanic ethnicity. Overall, case fatality rate (CFR) was low (0.4%), however, risk of death was significantly higher for American Indian/Alaska Natives (relative risk [RR] = 5.4) and Asian/Pacific Islanders (RR = 5.7) compared with persons of white race. Children aged < 10 years continue to experience the highest CFR (1.6%). Higher incidence of SFG rickettsioses and decreased CFR likely result from increased reporting of tick-borne disease including those caused by less pathogenic species. Recently, fewer cases have been confirmed using species-specific laboratory methods (such as cell culture and DNA detection using polymerase chain reaction [PCR] assays), causing a clouded epidemiological picture. Use of PCR and improved documentation of clinical signs, such as eschars, will better differentiate risk factors, incidence, and clinical outcomes of specific rickettsioses in the future.

Citing Articles

Bioelectric profiling of Rickettsia montanensis in Vero cells utilizing dielectrophoresis.

Doost N, Yaram S, Wagner K, Garg H, Srivastava S J Biol Eng. 2025; 19(1):18.

PMID: 39966846 PMC: 11837300. DOI: 10.1186/s13036-025-00487-y.


Long-Term Protective Immunity against Infection Induced by a Genetically Modified Live Vaccine.

Madesh S, McGill J, Jaworski D, Ferm J, Liu H, Fitzwater S Vaccines (Basel). 2024; 12(8).

PMID: 39204029 PMC: 11360114. DOI: 10.3390/vaccines12080903.


Emerging Tick-borne Infections in the Upper Midwest and Northeast United States Among Patients With Suspected Anaplasmosis.

Reller M, Clemens E, Bakken J, Dumler J Open Forum Infect Dis. 2024; 11(4):ofae149.

PMID: 38651141 PMC: 11034950. DOI: 10.1093/ofid/ofae149.


Microbiome of Invasive Tick Species in North Carolina, USA.

Ponnusamy L, Travanty N, Watson D, Seagle S, Boyce R, Reiskind M Insects. 2024; 15(3).

PMID: 38535349 PMC: 10970973. DOI: 10.3390/insects15030153.


Severe murine typhus complicated by multiple organ dysfunctions: A case report.

Muco E, Karruli A, Dajlani A, Zerja A, Bego A Caspian J Intern Med. 2024; 15(1):188-192.

PMID: 38463928 PMC: 10921100. DOI: 10.22088/cjim.15.1.23.


References
1.
Regan J, Traeger M, Humpherys D, Mahoney D, Martinez M, Emerson G . Risk factors for fatal outcome from rocky mountain spotted Fever in a highly endemic area-Arizona, 2002-2011. Clin Infect Dis. 2015; 60(11):1659-66. PMC: 4706357. DOI: 10.1093/cid/civ116. View

2.
Todd S, Dahlgren F, Traeger M, Beltran-Aguilar E, Marianos D, Hamilton C . No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015; 166(5):1246-51. DOI: 10.1016/j.jpeds.2015.02.015. View

3.
Holman R, Paddock C, Curns A, Krebs J, McQuiston J, Childs J . Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy. J Infect Dis. 2001; 184(11):1437-44. DOI: 10.1086/324372. View

4.
Traeger M, Regan J, Humpherys D, Mahoney D, Martinez M, Emerson G . Rocky mountain spotted fever characterization and comparison to similar illnesses in a highly endemic area-Arizona, 2002-2011. Clin Infect Dis. 2015; 60(11):1650-8. PMC: 4699465. DOI: 10.1093/cid/civ115. View

5.
Childs J, Paddock C . Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn?. Am J Trop Med Hyg. 2002; 66(5):450-7. DOI: 10.4269/ajtmh.2002.66.450. View